2021 CPIP-I Case 9: Hematology – Diagnostic Approach to Blastic-Appearing Hematolymphoid Neoplasms
2021 CPIP-I Case 9: Hematology – Diagnostic Approach to Blastic-Appearing Hematolymphoid Neoplasms is organized by College of American Pathologists (CAP).
Launch Date: September 20, 2021
Expiration Date: September 19, 2024 12:00 AM (ET)
Description:
Acute myeloid leukemia and blastic-appearing hematolymphoid neoplasms may present in a variety of ways. These critical diagnoses require timely identification to enable prompt initiation of appropriate therapy. The pathologist plays a crucial role in ensuring the use of appropriate diagnostic, predictive, and prognostic ancillary studies to enable cost-effective, high-quality care.
Objectives:
After completing this activity, you should be able to:
• Discriminate acute myeloid leukemia (AML) from other blastic-appearing hematolymphoid neoplasms.
• Describe the characteristic clinical, morphologic, immunophenotypic, and genetic features of several important subtypes of AML.
• Describe the recommended evidence-based predictive and prognostic tests once a diagnosis of AML has been established.